Latest News and Press Releases

-- The ALS Association is the world's leading funder of amyotrophic lateral sclerosis (ALS) research -- -- The Hoffman ALS Clinical Trial Awards Program was created to fund early- to mid-stage...

Data from the KT-621 BROADEN2 Phase 2b AD patient trial expected to be reported by mid-2027 KT-621 BREADTH Phase 2b trial in asthma on track to initiate in 1Q26 Completed dosing in KT-621...

November 24, 2025 Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) announced today that the University of Bonn,...

Cellular therapy laromestrocel Phase 2 clinical trial data in Alzheimer's disease selected for poster presentation at CTAD 2025.

Vail, Colorado, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has partnered with Neuromuscular Dynamics, LLC (NMD) to launch a clinical trial evaluating the...

SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing...

Boston, Nov. 17, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Artificial Intelligence (AI) in Pharmaceuticals: Global Markets” is projected to grow from $3.8 billion in...

Successful phase 1 with prolonged infusion duration could offer an effective solution for irreversibly stopping harmful inflammatory responses in sepsis.

New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatmentAll six patients responded positively to the combination...

Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea & Vomiting Induced by GLP-1 Receptor Agonist Semaglutide